Trials / Conditions / Tall Cell Variant Thyroid Gland Papillary Carcinoma
Tall Cell Variant Thyroid Gland Papillary Carcinoma
3 registered clinical trials studyying Tall Cell Variant Thyroid Gland Papillary Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated T NCT03914300 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) NCT02973997 | Academic and Community Cancer Research United | Phase 2 |
| Completed | Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer NCT01811212 | National Cancer Institute (NCI) | Phase 2 |